Your search returned 69 studies. (Get alerts for new studies):
- Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer
Conditions: Rectal Cancer
3 Locations available
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duoden
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Pancreatic Cancer - Periampullary Adenocarcinoma - Small Intestine Cancer
2 Locations available
- Study of REOLYSIN® in Combination With FOLFIRI in Patients With Oxaliplatin Refractory/Intolerant KRAS Mutant Colorectal Cancer
Conditions: Oxaliplatin Refractory/Intolerant KRAS Mutant Colorectal Cancer
3 Locations available
- Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed
Conditions: Lung Cancer
21 Locations available
- Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
Conditions: Testicular Cancer - Germ Cell Neoplasm
1 Location available
- Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer
Conditions: Breast Cancer
1 Location available
- Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer
Conditions: Pancreatic Cancer
5 Locations available
- HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
Conditions: Liver Cancer - Advanced Cancer
1 Location available
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
738 Locations available
- Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
Conditions: Cervical Cancer
12 Locations available
- Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
Conditions: Cancer
2 Locations available
- Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors
Conditions: Extragonadal Germ Cell Tumor - Ovarian Cancer - Testicular Germ Cell Tumor
9 Locations available
- Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Conditions: Advanced Cancers
1 Location available
- Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
29 Locations available
- Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Hereditary Breast and Ovarian Cancer Syndrome - Unspecified Adult Solid Tumor, Protocol Specific
6 Locations available
- Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin
Conditions: Colorectal Cancer - Esophageal Cancer - Gastric Cancer - Small Bowel Cancer - Pancreatic Cancer
1 Location available
- Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Canc
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
16 Locations available
- Veliparib and Carboplatin in Treating Women With HER2-Negative Metastatic Breast Cancer
Conditions: Breast Cancer
3 Locations available
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer
Conditions: Bladder Cancer - Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Lung Cancer - Pancreatic Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter
5 Locations available
- GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors
Conditions: Solid Cancers
3 Locations available
- LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer
2 Locations available
- FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
1 Location available
- Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
Conditions: Breast Cancer
2 Locations available
- Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer - Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Primary Appendiceal Tumor
Conditions: Peritoneal Cavity Cancer
2 Locations available
- Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastro
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
204 Locations available
- Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
3 Locations available
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Fallopian Tube Cancer - Ovarian Cancer
130 Locations available
- Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab
Conditions: Advanced Cancers
1 Location available
- VTX-2337 and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal C
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
6 Locations available
- Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Advanced Lymphoma, Multiple Myeloma, or Solid Tumors
Conditions: Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Precancerous Condition - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Salivary Gland Squamous Cell Carcinoma - Stage 0 Hypopharyngeal Cancer - Stage 0 Laryngeal Cancer - Stage 0 Lip and Oral Cavity Cancer - Stage 0 Nasopharyngeal Cancer - Stage 0
1 Location available
- The Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide or In Combination With Carboplatin and Paclitaxel Versus
Conditions: Metastatic Breast Cancer
3 Locations available
- Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1
Conditions: Metastatic Pancreatic Cancer - ERCC1
1 Location available
- Erlotinib Hydrochloride and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
Conditions: Squamous Cell Carcinoma of the Skin - Stage I Squamous Cell Carcinoma of the Hypopharynx - Stage I Squamous Cell Carcinoma of the Larynx - Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage I Squamous Cell Carcinoma of the Oropharynx - Sta
1 Location available
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
127 Locations available
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Conditions: Head and Neck Cancer - Lung Cancer - Lip Cancer - Lip Neoplasms - Head and Neck Cancers
1 Location available
- Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab
Conditions: Advanced Cancers
1 Location available
- High-Dose Methotrexate and Liposomal Cytarabine in Treating Patients With Central Nervous System (CNS) Metastases From Breast Cancer
Conditions: Stage IV Breast Cancer - Central Nervous System Involvement/Metastases - Leptomeningeal Metastases - Recurrent Breast Cancer - Tumors Metastatic to Brain
1 Location available
- Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies
Conditions: Solid Tumor - Breast Cancer - Ovarian Cancer - Pancreatic Cancer - Non-Small Cell Lung
2 Locations available
- Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combina
Conditions: Chemotherapeutic Agent Toxicity - Colorectal Cancer - Neuropathy - Neurotoxicity
401 Locations available
- Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Hereditary Breast/Ovarian Cancer - BRCA1 - Hereditary Breast/Ovarian Cancer - BRCA2 - Male Breast Cancer - Progesterone Receptor-negative Breast Cancer - Recurrent Breast Cancer - Stage IIIC Breast Cancer - Stage
1 Location available
- Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Esophagus - Adenocarcinoma of the Gastroesophageal Junction - Diffuse Adenocarcinoma of the Stomach - Intestinal Adenocarcinoma of the Stomach - Mixed Adenocarcinoma of the Stomach - Recurrent Esophageal Cancer - Recurrent Gastric Ca
1 Location available
- Bevacizumab With Capecitabine and Oxaliplatin in Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater
Conditions: Gastrointestinal Cancers
1 Location available
- Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions: Cervical Cancer
7 Locations available
- Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Conditions: Cognitive/Functional Effects - Colorectal Cancer - Neurotoxicity
307 Locations available
- Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer
Conditions: Biliary Tract Cancer - Gallbladder Cancer
2 Locations available
- Veliparib, Pegylated Liposomal Doxorubicin Hydrochloride, and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cance
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
4 Locations available
- Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix
Conditions: Carcinoma of the Appendix - Primary Peritoneal Cavity Cancer
3 Locations available
- Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis
Conditions: Peritoneal Cancer
1 Location available
- Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
Conditions: Pancreatic Cancer
1 Location available
- Oxaliplatin, Capecitabine, Cetuximab, and Radiation Therapy Followed By Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Conditions: Colorectal Cancer
116 Locations available
- Veliparib With or Without Carboplatin in Treating Patients With Stage III or Stage IV Breast Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer
20 Locations available
- Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Conditions: Salivary Gland Squamous Cell Carcinoma - Stage II Salivary Gland Cancer - Stage II Squamous Cell Carcinoma of the Hypopharynx - Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage II Squamous Cell Carcinoma of the Oropharynx - Stage II Ver
1 Location available
- Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy
Conditions: Neuropathy - Gastrointestinal Cancer
1 Location available
- A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With
Conditions: Non-Small -Cell Lung Cancer
1 Location available
- A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
Conditions: Mouth Cancer - Lip Cancer - Throat Cancer - Lip Neoplasms - Head and Neck Cancers
1 Location available
- Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Treating Patients With Colorectal Cancer That Has Spr
Conditions: Colorectal Cancer - Metastatic Cancer
1 Location available
- Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx - Stage III Squamous Cell Carcinoma of the Larynx - Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage III Squamous Cell Carcinoma of the Nasopharynx - Stage III Squamous Cell Carcinom
9 Locations available
- A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ova
Conditions: Cancer - Carcinoma - Fallopian Tube Cancer - Gynecological Malignancies - Metastases - Oncology - Ovarian Cancer - Solid Tumors - Tumors
8 Locations available
- A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
Conditions: Cholangiocarcinoma - Biliary Tract Cancer - Gallbladder Cancer
1 Location available
- 5-Azacytidine and Oxaliplatin With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy
Conditions: Advanced Cancer - Solid Tumor - Lymphoma
1 Location available
- Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer
Conditions: Larynx Cancer - Lip Cancer - Oral Cavity Cancer - Pharyngeal Cancer - Oropharyngeal Cancer
1 Location available
- Carboplatin, Pegylated Liposomal Doxorubicin Hydrochloride, and Everolimus in Treating Patients With Relapsed Ovarian Epithelial, Fallopian Tube, or P
Conditions: Fallopian Tube Cancer - Peritoneal Cavity Cancer - Recurrent Ovarian Epithelial Cancer
1 Location available
- Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer
Conditions: Liver Neoplasms
1 Location available
- Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney
Conditions: Cancer
17 Locations available
- Safety and Pharmacology of GDC-0068 in Combination With Either Docetaxel or Fluoropyrimidine Plus Oxaliplatin in Patients With Advanced Solid Tumors
Conditions: Solid Cancers
2 Locations available
- Abiraterone Acetate With or Without Veliparib in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
9 Locations available
|